Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Shares Traded Last Trade
  5.50 0.32% 1,730.00 819,790 16:35:00
Bid Price Offer Price High Price Low Price Open Price
1,738.00 1,739.00 1,757.50 1,716.00 1,726.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1,887.87 402.27 134.81 11.4 4,005
Last Trade Time Trade Type Trade Size Trade Price Currency
18:28:17 O 1,603 1,735.032 GBX

Hikma Pharmaceuticals (HIK) Latest News (1)

More Hikma Pharmaceuticals News
Hikma Pharmaceuticals Investors    Hikma Pharmaceuticals Takeover Rumours

Hikma Pharmaceuticals (HIK) Discussions and Chat

Hikma Pharmaceuticals Forums and Chat

Date Time Title Posts
25/1/202310:50Hikma Pharmaceuticals1,714
13/1/201515:12 *** Hikma ***98

Add a New Thread

Hikma Pharmaceuticals (HIK) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2023-02-07 18:28:171,735.031,60327,812.56O
2023-02-07 17:59:031,734.394,53278,602.51O
2023-02-07 17:58:501,735.2662110,775.99O
2023-02-07 17:55:281,730.00351.90O
2023-02-07 17:55:121,730.0024415.20O
View all Hikma Pharmaceuticals trades in real-time

Hikma Pharmaceuticals (HIK) Top Chat Posts

Top Posts
Posted at 07/2/2023 08:20 by Hikma Pharmaceuticals Daily Update
Hikma Pharmaceuticals Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker HIK. The last closing price for Hikma Pharmaceuticals was 1,724.50p.
Hikma Pharmaceuticals Plc has a 4 week average price of 1,607.50p and a 12 week average price of 1,411p.
The 1 year high share price is 2,137p while the 1 year low share price is currently 1,174.50p.
There are currently 231,498,391 shares in issue and the average daily traded volume is 468,822 shares. The market capitalisation of Hikma Pharmaceuticals Plc is £4,004,922,164.30.
Posted at 25/10/2022 12:56 by swinsco
Surely at a take over price. Just anybody take it over.. just put it out of its misery.
Posted at 30/9/2022 09:32 by cumnor
Bought in here at £13 avg. Now the diversity nonsense is out of the way these guys (and gals I suppose) need to up the ante on their dividend payments if they wish to recover the share price.....
Posted at 28/9/2022 12:36 by boadicea
This morning's price action seems to anticipate that happening.
Posted at 15/9/2022 11:01 by swinsco
Jeffries have just cut Hik price target to 2020 from 2200 and keep it a buy rating. Broker nonsense!
Posted at 01/9/2022 10:56 by mjneish
Good to see HIK outperforming the wider market at the moment. FTSE down 1.5% at the moment, and HIK down only 1%. :)
Posted at 26/8/2022 16:49 by mjneish
I've run a Piotroski F-score on HIK and got a score of 7 out of 9 (scores of 8 or 9 are considered good). They narrowly miss out on a score of 8 by a fraction of a percent.

This is using the previous two years' final results, and so before the erosion of their generics business really started to bite.

Having never done an F-score before, I'd be happy to share details of the calculation just in case someone who knows about it can confirm that it's been correctly done. It will be quite long-winded.

Posted at 18/8/2022 19:32 by cumnor
Punters and IIs are tiring of indebted companies like Hikma which paid divis of 2% for past couple of years, promised the earth and fail to deliver, as recent results show. Meanwhile directors pay themselves huge salaries and bonuses but expect investors to pay dear for the measly dividend. This could have been more generous and the recent falls (not just here) in poor payers share prices reflect a change in attitude to greedy directors.
Needs to see a divi of 5% plus before I'd touch this.

Posted at 04/8/2022 09:06 by adamb1978
Even taking historic earnings, PE is only around 11x. It feels like there's a lot of negativity built into the share price here. To justify this sort of multiple, you need to believe that the business is going to be more of less flat going forwards

No investment is a sure thing, and they're all an assessment of upside and downside potential. It feels to me that the multiple provides for a lot of downside protection here, and probably far too much

Posted at 04/4/2022 09:35 by netcurtains
blue: That is the point, asuming there is nothing fundamentally wrong with HIK, it does appear to be quite cheap.

HIK Pe 15
GSK Pe 19
AZN Pe (dont totally nuts).

Of the three, if nothing wrong with HIK, then HIK is probably looking pretty good.

Posted at 25/2/2022 09:06 by netcurtains
the normal TOTAL HIK share transactions on any given day are 1m (on good day) and 0.4m on average day and 02m on bad day.
So, if they bought 5% every other day, they could keep it up for at least three months
5% more buys could actually make the share price rise quite a lot over a month or two or three or four

I've edited this WINCANTON volume chart so you can see HIK volumes over the past year:

Hikma Pharmaceuticals share price data is direct from the London Stock Exchange
Your Recent History
Hikma Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230208 03:21:34